Alpha Tau Medical (DRTS) Research & Development (2021 - 2026)
Alpha Tau Medical (DRTS) reported Research & Development of $11.0 million for Q1 2026, up 53.07% on a YoY basis from $7.2 million in Q1 2025, and up 14.61% sequentially from $9.6 million in Q4 2025.
Alpha Tau Medical (DRTS) Research & Development (2021 - 2026) Analysis & Trends
Alpha Tau Medical (DRTS) has 6 years of Research & Development data on file, last reported at $11.0 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 53.07% year-over-year to $11.0 million; the trailing twelve-month figure through Mar 2026 stood at $35.9 million (up 29.3% YoY), and the FY2025 full-year result was $32.1 million, up 18.67% from the prior year.
- Research & Development advanced to $11.0 million in Q1 2026, from $9.6 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $11.0 million in Q1 2026 to a low of $4.8 million in Q3 2022.
- A 5-year average of $6.9 million and a median of $6.7 million in 2023 frame the typical range for Research & Development.
- Across the five-year window, Research & Development soared 139.15% in 2022 and retreated 7.49% in 2024, its largest moves.
- Tracing DRTS's Research & Development over 5 years: stood at $5.4 million in 2022, then surged by 39.22% to $7.5 million in 2023, then gained by 0.57% to $7.5 million in 2024, then increased by 27.12% to $9.6 million in 2025, then climbed by 14.61% to $11.0 million in 2026.
- Business Quant data shows DRTS's Research & Development at $11.0 million in Q1 2026, $9.6 million in Q4 2025, and $8.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Alpha Tau Medical | 1.12 Bn | 1.04 Bn | - | 10.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.98 Mn |
| Dec 31, 2025 | 9.58 Mn |
| Sep 30, 2025 | 8.31 Mn |
| Jun 30, 2025 | 7.01 Mn |
| Mar 31, 2025 | 7.17 Mn |
| Dec 31, 2024 | 7.53 Mn |
| Sep 30, 2024 | 6.17 Mn |
| Jun 30, 2024 | 6.87 Mn |
| Mar 31, 2024 | 6.45 Mn |
| Dec 31, 2023 | 7.49 Mn |
| Sep 30, 2023 | 6.67 Mn |
| Jun 30, 2023 | 5.96 Mn |
| Mar 31, 2023 | 6.31 Mn |
| Dec 31, 2022 | 5.38 Mn |
| Sep 30, 2022 | 4.83 Mn |
| Jun 30, 2022 | 5.45 Mn |
| Mar 31, 2022 | 5.24 Mn |
| Dec 31, 2021 | 3.23 Mn |
| Sep 30, 2021 | 3.03 Mn |
| Jun 30, 2021 | 3.00 Mn |